179 related articles for article (PubMed ID: 22316093)
1. Towards a quantitative understanding of the MITF-PIAS3-STAT3 connection.
Thingnes J; Lavelle TJ; Gjuvsland AB; Omholt SW; Hovig E
BMC Syst Biol; 2012 Feb; 6():11. PubMed ID: 22316093
[TBL] [Abstract][Full Text] [Related]
2. Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes.
Sonnenblick A; Levy C; Razin E
Mol Cell Biol; 2004 Dec; 24(24):10584-92. PubMed ID: 15572665
[TBL] [Abstract][Full Text] [Related]
3. A specific epitope of protein inhibitor of activated STAT3 is responsible for the induction of apoptosis in rat transformed mast cells.
Yagil Z; Kay G; Nechushtan H; Razin E
J Immunol; 2009 Feb; 182(4):2168-75. PubMed ID: 19201870
[TBL] [Abstract][Full Text] [Related]
4. Identifying a common molecular mechanism for inhibition of MITF and STAT3 by PIAS3.
Levy C; Lee YN; Nechushtan H; Schueler-Furman O; Sonnenblick A; Hacohen S; Razin E
Blood; 2006 Apr; 107(7):2839-45. PubMed ID: 16368885
[TBL] [Abstract][Full Text] [Related]
5. A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor.
Levy C; Nechushtan H; Razin E
J Biol Chem; 2002 Jan; 277(3):1962-6. PubMed ID: 11709556
[TBL] [Abstract][Full Text] [Related]
6. The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response.
Yagil Z; Nechushtan H; Kay G; Yang CM; Kemeny DM; Razin E
Trends Immunol; 2010 May; 31(5):199-204. PubMed ID: 20181527
[TBL] [Abstract][Full Text] [Related]
7. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.
Kluge A; Dabir S; Kern J; Nethery D; Halmos B; Ma P; Dowlati A
Int J Cancer; 2009 Oct; 125(7):1728-34. PubMed ID: 19569236
[TBL] [Abstract][Full Text] [Related]
8. Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors.
Wan P; Hu Y; He L
Mol Cell Biochem; 2011 Aug; 354(1-2):241-6. PubMed ID: 21519923
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.
Jiao J; Zhang R; Li Z; Yin Y; Fang X; Ding X; Cai Y; Yang S; Mu H; Zong D; Chen Y; Zhang Y; Zou J; Shao J; Huang Z
Nat Commun; 2018 Jun; 9(1):2504. PubMed ID: 29950561
[TBL] [Abstract][Full Text] [Related]
10. Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors.
Dabir S; Kluge A; Aziz MA; Houghton JA; Dowlati A
Cancer Biol Ther; 2011 Jul; 12(2):139-51. PubMed ID: 21532337
[TBL] [Abstract][Full Text] [Related]
11. The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.
Dabir S; Kluge A; Dowlati A
Mol Cancer Res; 2009 Nov; 7(11):1854-60. PubMed ID: 19903771
[TBL] [Abstract][Full Text] [Related]
12. STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.
Swoboda A; Soukup R; Eckel O; Kinslechner K; Wingelhofer B; Schörghofer D; Sternberg C; Pham HTT; Vallianou M; Horvath J; Stoiber D; Kenner L; Larue L; Poli V; Beermann F; Yokota T; Kubicek S; Krausgruber T; Rendeiro AF; Bock C; Zenz R; Kovacic B; Aberger F; Hengstschläger M; Petzelbauer P; Mikula M; Moriggl R
Oncogene; 2021 Feb; 40(6):1091-1105. PubMed ID: 33323974
[TBL] [Abstract][Full Text] [Related]
13. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G
Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051
[TBL] [Abstract][Full Text] [Related]
14. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
[TBL] [Abstract][Full Text] [Related]
15. TRIM8 modulates STAT3 activity through negative regulation of PIAS3.
Okumura F; Matsunaga Y; Katayama Y; Nakayama KI; Hatakeyama S
J Cell Sci; 2010 Jul; 123(Pt 13):2238-45. PubMed ID: 20516148
[TBL] [Abstract][Full Text] [Related]
16. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
[TBL] [Abstract][Full Text] [Related]
17. PIAS3 suppresses damage in an Alzheimer's disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway.
Li C; Wang R; Zhang Y; Hu C; Ma Q
Mol Med; 2021 Nov; 27(1):150. PubMed ID: 34837964
[TBL] [Abstract][Full Text] [Related]
18. [The Importance of MITF Signaling Pathway in the Regulation of Proliferation and Invasiveness of Malignant Melanoma].
Urban P; Rabajdová M; Veliká B; Špaková I; Bolerázska B; Mareková M
Klin Onkol; 2016; 29(5):347-350. PubMed ID: 27739313
[TBL] [Abstract][Full Text] [Related]
19. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.
Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J
Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977
[TBL] [Abstract][Full Text] [Related]
20. Role played by microphthalmia transcription factor phosphorylation and its Zip domain in its transcriptional inhibition by PIAS3.
Levy C; Sonnenblick A; Razin E
Mol Cell Biol; 2003 Dec; 23(24):9073-80. PubMed ID: 14645519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
